Cart
sales@molnova.com
JG-2016
CAS No. 2887480-87-5
JG-2016( —— )
Catalog No. M37309 CAS No. 2887480-87-5
JG-2016, as a small molecule histone acetyltransferase 1 (HAT1) inhibitor, inhibits the growth of human cancer cell lines, inhibits enzyme activity in cellulose, and interferes with tumor growth.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 311 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 455 | In Stock |
|
| 25MG | 905 | In Stock |
|
| 50MG | 1423 | In Stock |
|
| 100MG | 1841 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJG-2016
-
NoteResearch use only, not for human use.
-
Brief DescriptionJG-2016, as a small molecule histone acetyltransferase 1 (HAT1) inhibitor, inhibits the growth of human cancer cell lines, inhibits enzyme activity in cellulose, and interferes with tumor growth.
-
DescriptionJG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1), with an IC50 of 14.8 μM in the HAT1 acetylation assays.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHistone Acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2887480-87-5
-
Formula Weight376.84
-
Molecular FormulaC18H21ClN4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (265.36 mM; Ultrasonic )
-
SMILESO=C1N=C2C(=NC=3C=C(Cl)C(=CC3N2CCOCC(C)C)CC)C(=O)N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Joshua James GRUBER, et al. Modulators of histone acetyltransferase 1 and methods of treatment thereof. Patent, WO2022272313A1.
molnova catalog
related products
-
Isorhamnetin-3-O-rha...
Isorhamnetin-3-O-rhamnoside
-
Wilforol A
Wilforol A ((-)-Wilforol A), plant metabolite, is a pentacyclic triterpenoid. Wilforol A can be used for the research of various biochemical studies.
-
IDR-1
IDR-1 is an antimicrobial peptide that is active against Gram-positive and Gram-negative bacteria. IDR-1 counters infection by selective modulation of innate immunity without obvious toxicities. IDR-1 has anti-inflammatory and anti-infective properties, enhances the levels of monocyte chemokines, and attenuates pro-inflammatory cytokine release.
